ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

ACON Aclarion Inc

0.293
0.0102 (3.61%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Aclarion Inc ACON 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.0102 3.61% 0.293 13:00:01
개장가 저가 고가 종가 전일 종가
0.30 0.2845 0.30 0.2921 0.2828
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
25/04/202422:14GLOBEAclarion’s Nociscan Solution to Play Key Role in..
07/03/202406:09EDGAR2Form SC 13G - Statement of acquisition of beneficial..
04/03/202422:00GLOBEAclarion Announces Publication of Compelling Peer-Reviewed..
28/02/202405:22GLOBEAclarion Announces Closing of $3.0 Million Public Offering
28/02/202404:00EDGAR2Form 8-K - Current report
28/02/202400:46EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
27/02/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
26/02/202423:15GLOBEAclarion Announces Pricing of $3.0 Million Public Offering
24/02/202401:46EDGAR2Form S-1/A - General form for registration of securities..
22/02/202407:25EDGAR2Form 8-K - Current report
22/02/202405:02EDGAR2Form S-1/A - General form for registration of securities..
07/02/202407:32EDGAR2Form S-1/A - General form for registration of securities..
05/02/202422:00GLOBEAclarion Announces Successful Financings; Plans to Launch..
02/02/202407:16EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
01/02/202407:26EDGAR2Form S-1/A - General form for registration of securities..
29/01/202420:04EDGAR2Form 8-K - Current report
23/01/202423:53EDGAR2Form 8-K - Current report
23/01/202406:48EDGAR2Form S-1 - General form for registration of securities under..
22/01/202422:00GLOBEAclarion Expands Nociscan Access Into Phoenix With Key..
17/01/202422:00GLOBEAclarion Announces Updated Product Release That Expands MRI..
13/01/202406:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
08/01/202422:00GLOBEAclarion and ATEC Execute Strategic Partnership Agreement to..
04/01/202422:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
04/01/202422:00EDGAR2Form 8-K - Current report
03/01/202402:00GLOBEAclarion Announces Reverse Stock Split
29/12/202320:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
20/12/202306:30EDGAR2Form 8-K - Current report
12/12/202306:55EDGAR2Form S-1 - General form for registration of securities under..
27/11/202322:00GLOBEAclarion Announces Key Commercial Milestone With Completion..
23/11/202306:01EDGAR2Form 8-K - Current report
17/11/202306:58EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
13/11/202320:00EDGAR2Form DEF 14A - Other definitive proxy statements
08/11/202322:00GLOBEAclarion Announces Achievement of Goal to Enroll 10 Leading..
06/11/202322:00GLOBEAclarion Expands Immediate Nociscan Access Into New York..
02/11/202305:15EDGAR2Form PRE 14A - Other preliminary proxy statements
01/11/202321:00GLOBEAclarion Presents at the NIH HEAL Initiative Fall Meeting
31/10/202306:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
25/10/202321:30GLOBEAclarion Announces Signing of Commercial Agreement With..
24/10/202321:45GLOBEAclarion Announces Nociscan® Cost-Effectiveness Poster..
23/10/202321:55EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
23/10/202320:00GLOBEAclarion Announces Signing Strategic Partnership Letter of..
23/10/202319:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
21/10/202304:08EDGAR2Form S-1/A - General form for registration of securities..
11/10/202304:34EDGAR2Form S-1 - General form for registration of securities under..
10/10/202321:30EDGAR2Form 8-K - Current report
02/10/202321:00GLOBEAclarion Provides Updated Investor Presentation and..
28/09/202320:48EDGAR2Form 8-K - Current report
08/09/202305:01EDGAR2Form 8-K - Current report
01/09/202305:01EDGAR2Form 8-K - Current report
26/08/202305:42EDGAR2Form 8-K - Current report

최근 히스토리

Delayed Upgrade Clock